Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Effect of Age on Stroke Prevention Therapy in Patients with Atrial Fibrillation: The Atrial Fibrillation Investigators
Stroke 40:1410-1416, van Walraven,C.,et al, 2009
Does the Combination of Warfarin and Aspirin Have a Place in Secondary Stroke Prevention? Yes
Stroke 40:1942-1943,1946, Furlan,A.J., 2009
Progress in Secondary Stroke Prevention
Ann Neurol 63:418-427, Romano,J.G. &Sacco,R.L., 2008
Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999
Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998
Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Cerebral Ischemia with Mitral Valve Prolapse
Am Heart J 113:1308-1315, Wolf,P.A.,et al, 1987
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025
Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
NEJM 393:1191-1201, Tao,C.,et al, 2025
Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Stroke 56:3127-3137, Rodriguez-Caliemnes,A.,et al, 2025
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024
Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke A Post Hoc Analysis of the ARCADIA Randomized Clinical Trial
JAMA Neurol 81:957-965, Navi,B.B.,et al, 2024
Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source
Neurol 103:e209949, Grannam,M.,et al, 2024
Cerebrovascular Events in Patients Undergoing Transcatheter Aortic Valve Replacement:A Review
Stroke 55:2754-2764, Patel,K.P.,et al, 2024
2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024
Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023
Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023
Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
NEJM 388:2025-2095, Zi,W.,et al, 2023
Antiplatelet Therapy or Not for Asymptomatic/Incidental Lacunar Infarction
Stroke 54:1954-1959, Bilski.A.,et al, 2023
Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023
Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023
Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack
Ann Neurol 91:380-388, Wang, A.,et al, 2022
Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022
Oral Antiplatelet Therapy for Acute Ischemic Stroke
Stroke 53:e453-e454, Minhas, J.S.,et al, 2022
Natural History of Carotid Artery Free-Floating Thrombus-A Single Center, Consecutive Cohort Analysis
Front Neurol doi:10.3389/fneur.2022.993559;2022, Muller,M.D.,et al, 2022
Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021
Use of Dual Antiplatelet Therapy Following Ischemic Stroke
Stroke 51:e78-e80, Dong, J.,et al, 2020
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
Stroke 51:1616-1619, Beharry, J.,et al, 2020
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Transient Ischemic Attack
NEJM 382:1933-1941, Amarenco, P., 2020
Antiplatelet Treatment to Prevent Early Recurrent Stroke
NEJM 383:276-278, Rothwell, P.M., 2020
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
NEJM 380:1906-1917, Diener, H.C.,et al, 2019
Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection
JAMA Neurol 76:657-664, Markus, H.S.,et al, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared with Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke
JAMA Neurol 76:774-782, Tillman, H.,et al, 2019
Can We Stop the Stuttering in Stroke? Interventions in 40 Patients with Acute Lacunes
J Neurol Sci 401:1-4, Hawkes, Maximliano A.,et al, 2019
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People with Antiphospholipid Syndrome
Stroke 49:e41-e42, Bala, M.M.,et al, 2018
Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
NEJM 379:215-225, 291, Johnston, S.C.,et al, 2018